{"id":"https://openalex.org/W2146363516","doi":"https://doi.org/10.1194/jlr.m200127-jlr200","title":"AZ 242, a novel PPAR\u03b1/\u03b3 agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats","display_name":"AZ 242, a novel PPAR\u03b1/\u03b3 agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats","alternate_titles":[],"publication_year":2002,"publication_date":"2002-10-29","ids":{"openalex":"https://openalex.org/W2146363516","doi":"https://doi.org/10.1194/jlr.m200127-jlr200","mag":"2146363516","pmid":"https://pubmed.ncbi.nlm.nih.gov/12401884"},"language":"en","primary_location":{"id":"doi:10.1194/jlr.m200127-jlr200","doi":"https://doi.org/10.1194/jlr.m200127-jlr200","is_oa":true,"landing_page_url":"https://doi.org/10.1194/jlr.m200127-jlr200","pdf_url":"http://www.jlr.org/article/S0022227520327607/pdf","source":{"id":"https://openalex.org/S11400418","display_name":"Journal of Lipid Research","issn_l":"0022-2275","issn":["0022-2275","1539-7262"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Lipid Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2146363516"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.jlr.org/article/S0022227520327607/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043100525","display_name":"Bengt Ljung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Bengt Ljung","raw_affiliation_strings":["AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden. bengt.ljung@astrazeneca.com","AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden. bengt.ljung@astrazeneca.com","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058888558","display_name":"Krister Bamberg","orcid":"https://orcid.org/0000-0002-0538-6083","observed_orcids":["https://orcid.org/0000-0002-0538-6083"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Krister Bamberg","raw_affiliation_strings":["AstraZeneca R&D, Research Area CV/GI, Mo\u0308lndal S 431 83 Mo\u0308lndal, Sweden","AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Research Area CV/GI, Mo\u0308lndal S 431 83 Mo\u0308lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112063078","display_name":"Bj\u00f6rn Dahll\u00f6f","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Bj\u00f6rn Dahll\u00f6f","raw_affiliation_strings":["AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075229483","display_name":"Ann Kjellstedt","orcid":"https://orcid.org/0000-0001-6804-0584","observed_orcids":["https://orcid.org/0000-0001-6804-0584"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ann Kjellstedt","raw_affiliation_strings":["AstraZeneca R&D, Research Area CV/GI, Mo\u0308lndal S 431 83 Mo\u0308lndal, Sweden","AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Research Area CV/GI, Mo\u0308lndal S 431 83 Mo\u0308lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066815897","display_name":"Nicholas D. Oakes","orcid":"https://orcid.org/0000-0003-3012-869X","observed_orcids":["https://orcid.org/0000-0003-3012-869X"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Nicholas D. Oakes","raw_affiliation_strings":["AstraZeneca R&D, Research Area CV/GI, Mo\u0308lndal S 431 83 Mo\u0308lndal, Sweden","AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Research Area CV/GI, Mo\u0308lndal S 431 83 Mo\u0308lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032506456","display_name":"J\u00f6rgen \u00d6stling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"J\u00f6rgen \u00d6stling","raw_affiliation_strings":["AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lennart Svensson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Lennart Svensson","raw_affiliation_strings":["AstraZeneca R&D, Research Area CV/GI, Mo\u0308lndal S 431 83 Mo\u0308lndal, Sweden","AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Research Area CV/GI, Mo\u0308lndal S 431 83 Mo\u0308lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058639659","display_name":"Germ\u00e1n Camejo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Germ\u00e1n Camejo","raw_affiliation_strings":["AstraZeneca R&D, Research Area CV/GI, Mo\u0308lndal S 431 83 Mo\u0308lndal, Sweden","AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, Research Area CV/GI, Mo\u0308lndal S 431 83 Mo\u0308lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"AstraZeneca R&D, Research Area CV/GI, M\u00f6lndal S 431 83 M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5043100525"],"corresponding_institution_ids":["https://openalex.org/I4210143795"],"apc_list":{"value":3430,"currency":"USD","value_usd":3430},"apc_paid":{"value":3430,"currency":"USD","value_usd":3430},"fwci":4.1795,"has_fulltext":true,"cited_by_count":115,"citation_normalized_percentile":{"value":0.95541078,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"43","issue":"11","first_page":"1855","last_page":"1863"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11457","display_name":"Adipose Tissue and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12975","display_name":"Paraoxonase enzyme and polymorphisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9679999947547913},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8230000138282776},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.906000018119812},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.9010000228881836},{"id":"https://openalex.org/keywords/hyperinsulinemia","display_name":"hyperinsulinemia","score":0.7870000004768372},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.9430000185966492},{"id":"https://openalex.org/keywords/fatty-acid-metabolism","display_name":"fatty acid metabolism","score":0.8119999766349792},{"id":"https://openalex.org/keywords/glucose-metabolism","display_name":"glucose metabolism","score":0.9760000109672546},{"id":"https://openalex.org/keywords/ob-ob-mice","display_name":"ob/ob mice","score":0.7099999785423279},{"id":"https://openalex.org/keywords/zucker-rats","display_name":"Zucker rats","score":0.7940000295639038},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.6779999732971191},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.7120000123977661},{"id":"https://openalex.org/keywords/adipogenic-differentiation","display_name":"adipogenesis","score":0.734000027179718},{"id":"https://openalex.org/keywords/liver-fatty-acid-binding-protein","display_name":"liver fatty acid binding protein","score":0.921999990940094},{"id":"https://openalex.org/keywords/cyp4a","display_name":"CYP4A","score":0.8489999771118164},{"id":"https://openalex.org/keywords/hepatic-gene-expression","display_name":"hepatic gene expression","score":0.41999998688697815}],"concepts":[{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.8819547891616821},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.863377571105957},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.8278724551200867},{"id":"https://openalex.org/C2780988686","wikidata":"https://www.wikidata.org/wiki/Q14375936","display_name":"Hyperinsulinemia","level":4,"score":0.7026817202568054},{"id":"https://openalex.org/C2776919658","wikidata":"https://www.wikidata.org/wiki/Q1467339","display_name":"Hypertriglyceridemia","level":4,"score":0.6096501350402832},{"id":"https://openalex.org/C17093226","wikidata":"https://www.wikidata.org/wiki/Q2734081","display_name":"Carbohydrate metabolism","level":2,"score":0.6038380861282349},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.5702719688415527},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.5457202792167664},{"id":"https://openalex.org/C4733338","wikidata":"https://www.wikidata.org/wiki/Q2792936","display_name":"Lipid metabolism","level":2,"score":0.5135517120361328},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5022296905517578},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5002167224884033},{"id":"https://openalex.org/C2777866211","wikidata":"https://www.wikidata.org/wiki/Q5572349","display_name":"Glucose uptake","level":3,"score":0.49111244082450867},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4804486930370331},{"id":"https://openalex.org/C2776991927","wikidata":"https://www.wikidata.org/wiki/Q14860867","display_name":"Fatty acid metabolism","level":3,"score":0.4462950825691223},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.37283653020858765},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.3433610796928406},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2924761176109314},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24817883968353271},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.24640196561813354},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.17062890529632568}],"mesh":[{"descriptor_ui":"D000476","descriptor_name":"Alkanesulfonates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001629","descriptor_name":"Bezafibrate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002934","descriptor_name":"Cinnamates","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003920","descriptor_name":"Diabetes Mellitus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005227","descriptor_name":"Fatty Acids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005947","descriptor_name":"Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008820","descriptor_name":"Mice, Obese","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010666","descriptor_name":"Phenylpropionates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011924","descriptor_name":"Rats, Zucker","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018160","descriptor_name":"Receptors, Cytoplasmic and Nuclear","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018160","descriptor_name":"Receptors, Cytoplasmic and Nuclear","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D050260","descriptor_name":"Carbohydrate Metabolism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D050356","descriptor_name":"Lipid Metabolism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1194/jlr.m200127-jlr200","doi":"https://doi.org/10.1194/jlr.m200127-jlr200","is_oa":true,"landing_page_url":"https://doi.org/10.1194/jlr.m200127-jlr200","pdf_url":"http://www.jlr.org/article/S0022227520327607/pdf","source":{"id":"https://openalex.org/S11400418","display_name":"Journal of Lipid Research","issn_l":"0022-2275","issn":["0022-2275","1539-7262"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Lipid Research","raw_type":"journal-article"},{"id":"pmid:12401884","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12401884","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of lipid research","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:ab22cbdbc31e4c66b2ea38f380e995e7","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ab22cbdbc31e4c66b2ea38f380e995e7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Lipid Research, Vol 43, Iss 11, Pp 1855-1863 (2002)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1194/jlr.m200127-jlr200","doi":"https://doi.org/10.1194/jlr.m200127-jlr200","is_oa":true,"landing_page_url":"https://doi.org/10.1194/jlr.m200127-jlr200","pdf_url":"http://www.jlr.org/article/S0022227520327607/pdf","source":{"id":"https://openalex.org/S11400418","display_name":"Journal of Lipid Research","issn_l":"0022-2275","issn":["0022-2275","1539-7262"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Lipid Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2146363516.pdf","grobid_xml":"https://content.openalex.org/works/W2146363516.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W36311596","https://openalex.org/W91098912","https://openalex.org/W1521959273","https://openalex.org/W1524478189","https://openalex.org/W1606639029","https://openalex.org/W1951826532","https://openalex.org/W1969698569","https://openalex.org/W1971834210","https://openalex.org/W1977666051","https://openalex.org/W1986349550","https://openalex.org/W2001396094","https://openalex.org/W2027149291","https://openalex.org/W2028212562","https://openalex.org/W2042618169","https://openalex.org/W2042627953","https://openalex.org/W2047399305","https://openalex.org/W2047957470","https://openalex.org/W2049702067","https://openalex.org/W2051583212","https://openalex.org/W2053837499","https://openalex.org/W2054851194","https://openalex.org/W2056726092","https://openalex.org/W2059395658","https://openalex.org/W2061245912","https://openalex.org/W2066524854","https://openalex.org/W2094083143","https://openalex.org/W2100131441","https://openalex.org/W2100400393","https://openalex.org/W2103116278","https://openalex.org/W2105532009","https://openalex.org/W2107021176","https://openalex.org/W2112327050","https://openalex.org/W2117836504","https://openalex.org/W2121496639","https://openalex.org/W2137046761","https://openalex.org/W2148877387","https://openalex.org/W2158609897","https://openalex.org/W2171716790","https://openalex.org/W2315900429","https://openalex.org/W2328529137","https://openalex.org/W2975364463"],"related_works":["https://openalex.org/W2162463137","https://openalex.org/W2081480453","https://openalex.org/W2102505274","https://openalex.org/W2402862211","https://openalex.org/W2381769800","https://openalex.org/W4304124312","https://openalex.org/W346112910","https://openalex.org/W2034565459","https://openalex.org/W2137606231","https://openalex.org/W2108672863"],"abstract_inverted_index":{"Abnormalities":[0],"in":[1,14,30,90,103,112,128,139,150],"fatty":[2,124],"acid":[3,125],"(FA)":[4],"metabolism":[5],"underlie":[6],"the":[7,20,56,104,156,185],"development":[8],"of":[9,19,34,41,61,80,122,136,145,160,187],"insulin":[10,78,86,164],"resistance":[11,165],"and":[12,23,59,84,99,119,166,172,193],"alterations":[13],"glucose":[15,173],"metabolism,":[16],"features":[17],"characteristic":[18],"metabolic":[21,191],"syndrome":[22],"type":[24,188],"2":[25,189],"diabetes":[26],"that":[27,70,155],"can":[28],"result":[29],"an":[31,115],"increased":[32],"risk":[33,196],"cardiovascular":[35],"disease.":[36],"We":[37],"present":[38],"pharmacodynamic":[39],"effects":[40,135,169],"AZ":[42,52,73,94,137,161],"242,":[43],"a":[44,131,180],"novel":[45],"peroxisome":[46],"proliferator":[47],"activated":[48,96],"receptor":[49],"(PPAR)alpha/gamma":[50],"agonist.":[51],"242":[53,74,95,138,162],"dose-dependently":[54],"reduced":[55],"hypertriglyceridemia,":[57],"hyperinsulinemia,":[58],"hyperglycemia":[60],"ob/ob":[62],"diabetic":[63],"mice.":[64,151],"Euglycemic":[65],"hyperinsulinemic":[66],"clamp":[67],"studies":[68],"showed":[69],"treatment":[71,186],"with":[72,101],"(1":[75],"micromol/kg/d)":[76],"restored":[77],"sensitivity":[79],"obese":[81],"Zucker":[82],"rats":[83],"decreased":[85],"secretion.":[87],"In":[88],"vitro,":[89],"reporter":[91],"gene":[92],"assays,":[93],"human":[97],"PPARalpha":[98],"PPARgamma":[100,117],"EC(50)":[102],"micro":[105],"molar":[106],"range.":[107],"It":[108],"also":[109],"induced":[110],"differentiation":[111],"3T3-L1":[113],"cells,":[114,130],"established":[116],"effect,":[118],"caused":[120],"up-regulation":[121],"liver":[123],"binding":[126],"protein":[127],"HepG-2":[129],"PPARalpha-mediated":[132,134],"effect.":[133],"vivo":[140],"were":[141],"documented":[142],"by":[143],"induction":[144],"hepatic":[146],"cytochrome":[147],"P":[148],"450-4A":[149],"The":[152],"results":[153],"indicate":[154],"dual":[157],"PPARalpha/gamma":[158],"agonism":[159],"reduces":[163],"has":[167],"beneficial":[168],"on":[170],"FA":[171],"metabolism.":[174],"This":[175],"effect":[176],"profile":[177],"could":[178],"provide":[179],"suitable":[181],"therapeutic":[182],"approach":[183],"to":[184],"diabetes,":[190],"syndrome,":[192],"associated":[194],"vascular":[195],"factors.":[197]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2146363516","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
